A novel and alternative approach to controlled release drug delivery system based on solid dispersion technique
Tài liệu tham khảo
Linn, 2012, Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo, Eur J Pharm Sci, 45, 336, 10.1016/j.ejps.2011.11.025
Kim, 2011, Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process, Int J Nanomedicine, 6, 2997
Chen, 2011, Preparation and characterization of emulsified solid dispersions containing docetaxel, Arch Pharm Res, 34, 1909, 10.1007/s12272-011-1111-2
Yan, 2012, Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes, Int J Pharm, 422, 202, 10.1016/j.ijpharm.2011.10.053
Tung, 2011, Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy, J Pharm Pharmacol, 63, 1539, 10.1111/j.2042-7158.2011.01360.x
Wu, 2011, Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability, Eur J Pharm Sci, 44, 610, 10.1016/j.ejps.2011.10.008
Moes, 2011, Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001), Int J Pharm, 420, 244, 10.1016/j.ijpharm.2011.08.041
Kovacic, 2011, Design of a drug delivery system with bimodal pH dependent release of a poorly soluble drug, Pharmazie, 66, 465
Tran, 2011, Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water soluble drug, Int J Pharm, 415, 83, 10.1016/j.ijpharm.2011.05.052
Kanaujia, 2011, Nanoparticle formation and growth during in vitro dissolution of ketoconazole solid dispersion, J Pharm Sci, 100, 2876, 10.1002/jps.22491
Patel, 2012, Characterization of ergocalciferol loaded solid lipid nanoparticles, J Food Sci, 77, N8, 10.1111/j.1750-3841.2011.02517.x
Perge, 2012, New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study, Int J Pharm, 422, 59, 10.1016/j.ijpharm.2011.10.027
Kim, 2011, Formulation optimization of solid dispersion of mosapride hydrochloride, Arch Pharm Res, 34, 1467, 10.1007/s12272-011-0908-3
Attama, 2011, In vitro properties of surface-modified solid lipid microspheres containing an antimalarial drug: halofantrine, Asian Pac J Trop Med, 4, 253, 10.1016/S1995-7645(11)60081-3
Bikiaris, 2011, Solid dispersions. Part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs, Expert Opin Drug Deliv, 8, 1501, 10.1517/17425247.2011.618181
Iqbal, 2011, Recent advances and patents in solid dispersion technology, Recent Pat Drug Deliv Formul, 5, 244, 10.2174/187221111797200551
Srinarong, 2011, Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations, Expert Opin Drug Deliv, 8, 1121, 10.1517/17425247.2011.598147
Warren, 2010, Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility, J Drug Target, 18, 704, 10.3109/1061186X.2010.525652
Tran, 2010, Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility, Expert Opin Drug Deliv, 7, 647, 10.1517/17425241003645910
Qian, 2010, Drug-polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development, J Pharm Sci, 99, 2941, 10.1002/jps.22074
Janssens, 2009, Review: physical chemistry of solid dispersions, J Pharm Pharmacol, 61, 1571, 10.1211/jpp.61.12.0001
Dhirendra, 2009, Solid dispersion: a review, Pak J Pharm Sci, 22, 234
Desai, 2006, Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release, Int J Pharm, 308, 115, 10.1016/j.ijpharm.2005.10.034
Iqbal, 2002, Controlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method, Drug Dev Ind Pharm, 28, 129, 10.1081/DDC-120002445
Dangprasirt, 1998, Development of diclofenac sodium release solid dispersion powders and capsules by freeze drying technique using ethylcellulose and chitosan as carriers, Drug Dev Ind Pharm, 24, 947, 10.3109/03639049809097274
Ozeki, 1995, Application of the solid dispersion method to the controlled release of medicine. VII. Release mechanism of a highly water-soluble medicine from solid dispersion with different molecular weights of polymer, Chem Pharm Bull, 43, 660, 10.1248/cpb.43.660
Ohara, 2005, Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose, Int J Pharm, 302, 95, 10.1016/j.ijpharm.2005.06.019
Huang, 2006, Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition, Drug Dev Ind Pharm, 32, 1185, 10.1080/03639040600832827
Kamada, 2002, Cyclodextrin conjugate-based controlled release system: repeated and prolonged-release of ketoprofen after oral administration in rats, J Control Release, 82, 407, 10.1016/S0168-3659(02)00171-2
Ghaly, 1992, Ethylcellulose as a carrier for controlled-release acetaminophen tablets, P R Health Sci J, 11, 159
Ozeki, 1995, Application of the solid dispersion method to the controlled release of medicine. VIII. Medicine release and viscosity of the hydrogel of a water-soluble polymer in a three-component solid dispersion system, Chem Pharm Bull, 43, 1574, 10.1248/cpb.43.1574
Yuasa, 1994, Application of the solid dispersion method to the controlled release of medicine. VI. Release mechanism of a slightly water soluble medicine and interaction between flurbiprofen and hydroxypropyl cellulose in solid dispersion, Chem Pharm Bull, 42, 354, 10.1248/cpb.42.354
Swain, 2011, Design and evaluation of sustained release solid dispersions of verapamil hydrochloride, Int J Pharm Sci Nanotechnol, 3, 1252
Tanaka, 2006, Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation, J Control Release, 112, 51, 10.1016/j.jconrel.2006.01.020
Chen, 2006, Particle design of three-component system for sustained release using a 4-fluid nozzle spray-drying technique, Chem Pharm Bull, 54, 1486, 10.1248/cpb.54.1486
Sugawara, 2005, The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulation, Eur J Pharm Sci, 26, 1, 10.1016/j.ejps.2005.02.017
Duarte, 2007, Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques, Int J Pharm, 332, 132, 10.1016/j.ijpharm.2006.09.041
Varshosaz, 2006, Preparation and characterization of metoprolol controlled-release solid dispersions, Drug Deliv, 13, 295, 10.1080/10717540500459308
Rathinaraj, 2010, Studies on dissolution behaviour of sustained release solid dispersions of nimodipine, Int J Pharm Sci Rev Res, 3, 77
Sahoo J, Murthy PN, Biswal S, Manik. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon® SR. AAPS Pharm Sci Tech 2009;10(1):27–33.
Verreck, 2005, The effect of pressurized carbon dioxide as a temporary plasticizer and foaming agent on the hot stage extrusion process and extrudate properties of solid dispersions of itraconazole with PVP-VA 64, Eur J Pharm Sci, 26, 349, 10.1016/j.ejps.2005.07.006
Kumar, 2008, Rheological characterization and drug release studies of gum exudates of Terminalia catappa Linn, AAPS Pharm Sci Tech, 9, 885, 10.1208/s12249-008-9101-5
Ozeki, 2000, Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol® interpolymer complex with various cross-linking degrees of Carbopol®, J Control Release, 63, 287, 10.1016/S0168-3659(99)00202-3
Ho, 2000, Influence of pluronic F-68 on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery, J Control Release, 68, 433, 10.1016/S0168-3659(00)00281-9
Li, 2006, In vitro controlled release of sodium ferulate from compritol 888 ATO-based matrix tablets, Int J Pharm, 324, 152, 10.1016/j.ijpharm.2006.06.006
Ozeki, 2005, Controlled release of drug via methylcellulose-carboxyvinylpolymer interpolymer complex solid dispersion, AAPS Pharm Sci Tech, 6, E231, 10.1208/pt060233
Ikeda, 2000, Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives, J Control Release, 66, 271, 10.1016/S0168-3659(99)00286-2
Yuasa, 1992, Application of the solid dispersion method to controlled release of medicine. II. Sustained release tablet using solid dispersion granule and the medicine release mechanism, Chem Pharm Bull, 40, 1592, 10.1248/cpb.40.1592
Yuasa, 1991, Application of the solid dispersion method to controlled release of medicine. I. Controlled release of water soluble medicine by using solid dispersion, Chem Pharm Bull, 39, 465, 10.1248/cpb.39.465
Ozeki, 1994, Application of the solid dispersion method to controlled release of medicine. V. Suppression mechanism of the medicine release rate in the three-component solid dispersion system, Chem Pharm Bull, 42, 337, 10.1248/cpb.42.337
Tanaka, 2005, Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine, J Control Release, 108, 386, 10.1016/j.jconrel.2005.08.024
Tran, 2009, Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug, Eur J Pharm Biopharm, 72, 83, 10.1016/j.ejpb.2008.12.009
Hong, 2008, Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by carbopol, Int J Pharm, 356, 121, 10.1016/j.ijpharm.2008.01.002
Rodriguez, 2003, In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery, Eur J Pharm Sci, 20, 125, 10.1016/S0928-0987(03)00181-7
Chen, 2009, Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin, Drug Dev Ind Pharm, 35, 131, 10.1080/03639040701657388
Chen, 2006, Particle design using a 4-fluid-nozzle spray-drying technique for sustained release of acetaminophen, Chem Pharm Bull, 54, 948, 10.1248/cpb.54.948
Chen, 2008, Preparation of functional composite particles of salbutamol sulfate using a 4-fluid nozzle spray-drying technique, Chem Pharm Bull, 56, 254, 10.1248/cpb.56.254
Ozawa, 2002, Preparation of solid dispersion for ethenzamide-carbopol and theophylline-carbopol systems using a twin screw extruder, Chem Pharm Bull, 50, 802, 10.1248/cpb.50.802
Zhu, 2006, Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms, Pharm Dev Technol, 11, 285, 10.1080/10409230600767551
Kakumanu, 2003, Supercritical fluid technology in pharmaceutical research, CRIPS, 4, 8
Hanna M, York P. Method and apparatus for the formation of particles. WO9501221 (1995).
Sencar-Bozic, 1997, Improvement of nifedipine dissolution characteristics using supercritical CO2, Int J Pharm, 148, 123, 10.1016/S0378-5173(96)04838-7
Kerc, 1999, Micronization of drugs using supercritical carbon dioxide, Int J Pharm, 182, 33, 10.1016/S0378-5173(99)00063-0
Jung, 2001, Particle design using supercritical fluids: literature and patent survey, J Supercrit Fluid, 20, 179, 10.1016/S0896-8446(01)00064-X
Bleich, 1996, Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process, J Microencapsul, 13, 131, 10.3109/02652049609052902
Juppo, 2003, Evaluation of solid dispersion particles prepared with SEDS, Int J Pharm, 250, 385, 10.1016/S0378-5173(02)00577-X
Palakodaty, 1998, Supercritical fluid processing of materials from aqueous solutions: the application of SEDS to lactose as a model substance, Pharm Res, 15, 1835, 10.1023/A:1011949805156
Randolph, 1993, Sub-micrometer-sized biodegradable particles of poly(l-lactic acid) via the gas antisolvent spray precipitation process, Biotechnol Prog, 9, 429, 10.1021/bp00022a010
Elvassore, 2001, Production of different morphologies of biocompatible polymeric materials by supercritical CO2 antisolvent techniques, Biotechnol Bioeng, 73, 449, 10.1002/bit.1079
Huang, 2006, Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery effect of drug loading on release kinetics, Int J Pharm, 319, 44, 10.1016/j.ijpharm.2006.03.035
Ritger, 1987, A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, J Control Release, 5, 23, 10.1016/0168-3659(87)90034-4
Ritger, 1987, A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices, J Control Release, 5, 37, 10.1016/0168-3659(87)90035-6
Siepmann, 2001, Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC), Adv Drug Deliv Reviews, 48, 139, 10.1016/S0169-409X(01)00112-0
Mehta, 2002, Multi-unit controlled release systems of nifedipine and nifedipine: pluronic F-68 solid dispersions: characterization of release mechanisms, Drug Dev Ind Pharm, 28, 275, 10.1081/DDC-120002843
Khanfar, 1997, Dissolution behavior of sustained release formulations of indomethacin with Eudragit RS, Acta Pharm Hung, 67, 235
Perez, 1993, Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix, P R Health Sci J, 12, 263